ANPEP and leukemia: Anti MPO, CD13 and CD33 are the 3 IHC markers used consistently to detect blasts of myeloid lineage by the 3 major conglomerates in hematology namely European Group for the Immunological Characterization of Leukemias (EGIL), US–Canadian